# Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 62175-322-46. — FDA Safety Label Change

> Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.

**Manufacturer:** Lannett Company Inc.
**Date of action:** 20260610
**Canonical URL:** https://drugsmonitor.com/recall/70b75eee-be9e-431d-8724-9174eea55a54
**Last updated:** 2026-06-11

## Summary

Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 62175-322-46. (Lannett Company Inc.) — Safety Label Change on 20260610.

Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.

---

*Educational recall record from DrugsMonitor.com. Confirm details with FDA primary sources.*